Incidence of Loss to Follow-Up and Its Predictors Among Children with HIV on Antiretroviral Therapy at the University of Gondar Comprehensive Specialized Referral Hospital: A Retrospective Data Analysis

References

• Global H AIDS statistics–2019 fact sheet (2019). 2020.
   Google Scholar
• Wube M, Tesfaye A, Hawaze S. Antiretroviral therapy regimen change among HIV/AIDS patients in Nekemt Hospital: a primary care Hospital in Oromia Regional State, Ethiopia. J Appl Pharm Sci. 2013;3(8):36.
   Google Scholar
• Abebe N, Alemu K, Asfaw T, Abajobir AA. Predictors of mortality among HIV positive adults on antiretroviral therapy in Debre Markos Referral Hospital, Northwest Ethiopia. J AIDS HIV Res. 2014;6(1):19–27. doi:10.5897/JAHR2013.0275
   Google Scholar
• Organization WH. Retention in HIV programs: defining the challenges and identifying solutions: meeting report, 13–15 September 2011. 2012.
   Google Scholar
• Brinkhof MW, Dabis F, Myer L, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programs in lower-income countries. Bull World Health Organ. 2008;86:559–567. doi:10.2471/BLT.07.04424818670668
   PubMed Web of Science ®Google Scholar
• Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298. doi:10.1371/journal.pmed.004029817941716
   PubMed Web of Science ®Google Scholar
• Leroy V, Malateste K, Rabie H, et al. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr. 2013;62(2):208. doi:10.1097/QAI.0b013e31827b70bf23187940
   PubMedGoogle Scholar
• Melaku Z, Lulseged S, Wang C, et al. Outcomes among HIV‐infected children initiating HIV care and antiretroviral treatment in Ethiopia. Trop Med Int Health. 2017;22(4):474–484. doi:10.1111/tmi.1283428066962
   PubMedGoogle Scholar
• Walter J, Molfino L, Moreno V, et al. Long-term outcomes of a pediatric HIV treatment program in Maputo, Mozambique: a cohort study. Glob Health Action. 2015;8(1):26652. doi:10.3402/gha.v8.2665226287397
   PubMedGoogle Scholar
• McCormick NM, Nan L, Sando D, et al. Risk factors of loss to follow up among HIV positive pediatric patients in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2015;70(3):e73. doi:10.1097/QAI.000000000000078226247894
   PubMed Web of Science ®Google Scholar
• Berheto TM, Haile DB, Mohammed S. Predictors of loss to follow-up in patients living with HIV/AIDS after initiation of antiretroviral therapy. N Am J Med Sci. 2014;6(9):453. doi:10.4103/1947-2714.14163625317390
   PubMedGoogle Scholar
• Juergens S, Sawitri AA, Putra IA, Merati P. Predictors of loss to follow up and mortality among children 12 years receiving anti retroviral therapy during the first year at a referral hospital in Bali. Public Health Prev Med Arch. 2016;4:127–133. doi:10.24843/PHPMA.2016.v04.i02.p02
   Google Scholar
• Ekouevi DK, Azondekon A, Dicko F, et al. 12-month mortality and loss-to-program in antiretroviral-treated children: the IeDEA pediatric West African database to evaluate AIDS (pWADA), 2000–2008. BMC Public Health. 2011;11(1):519. doi:10.1186/1471-2458-11-51921718505
   PubMedGoogle Scholar
• Auld AF, Tuho MZ, Ekra KA, et al. Temporal trends in mortality and loss to follow-up among children enrolled in Cote d’Ivoire’s national antiretroviral therapy program. Pediatr Infect Dis J. 2014;33(11):1134–1140. doi:10.1097/INF.000000000000045725093975
   PubMedGoogle Scholar
• Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O’Shaughnessy MV. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16:1051–1058. doi:10.1097/00002030-200205030-0001211953472
   PubMed Web of Science ®Google Scholar
• Saumu WM, Maleche-Obimbo E, Irimu G, Kumar R, Gichuhi C, Karau B. Predictors of loss to follow-up among children attending HIV clinic in a hospital in rural Kenya. Pan Afr Med J. 2019;32. doi:10.11604/pamj.2019.32.216.18310
   PubMed Web of Science ®Google Scholar
• Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009;4(6):e5790. doi:10.1371/journal.pone.000579019495419
   PubMed Web of Science ®Google Scholar
• Bamidele-Abegunde D. Exploring Predictors of Loss-To-Care Among People Living with HIV. University of Pittsburgh; 2015.
   Google Scholar
• Biru M, Hallström I, Lundqvist P, Jerene D. Rates and predictors of attrition among children on antiretroviral therapy in Ethiopia: a prospective cohort study. PLoS One. 2018;13(2):e0189777. doi:10.1371/journal.pone.018977729408897
   PubMedGoogle Scholar
• Massavon W, Lundin R, Costenaro P, et al. Attrition and loss to follow-up among children and adolescents in a community home-based care HIV programme in Uganda. Pediat Therapeut. 2013;3(183):2161–2665.
   Google Scholar
• Hansudewechakul R, Sirisanthana V, Kurniati N, et al. Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia Pediatric HIV observational database. J Acquir Immune Defic Syndr. 2010;55(4):503. doi:10.1097/QAI.0b013e3181f5379a20842043
   PubMedGoogle Scholar
• Shroufi A, Gunguwo H, Dixon M, et al. HIV-infected adolescents in southern Africa can achieve good treatment outcomes: results from a retrospective cohort study. AIDS. 2013;27(12):1971. doi:10.1097/QAD.0b013e32836149ea23525033
   PubMed Web of Science ®Google Scholar
• Sengayi M, Dwane N, Marinda E, Sipambo N, Fairlie L, Moultrie H. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa. Glob Health Action. 2013;6(1):19248. doi:10.3402/gha.v6i0.1924823364098
   PubMedGoogle Scholar
• Federal Ministry of Health Ethiopia. National consolidated guidelines for comprehensive HIV prevention, care, and treatment. 2018.
   Google Scholar
• O’Brien ME, Clark RA, Besch CL, Myers L, Kissinger P. Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort. J Acquir Immune Defic Syndr. 2003;34(4):407–414. doi:10.1097/00126334-200312010-0000814615659
   PubMed Web of Science ®Google Scholar
• Massavon W, Barlow-Mosha L, Mugenyi L, et al. Factors determining survival and retention among HIV-infected children and adolescents in a community home-based care and a facility-based family-centered approach in Kampala, Uganda: a cohort study. Isrn aids. 2014;2014:1–13. doi:10.1155/2014/852489
   Google Scholar
• Bhatta L, Klouman E, Deuba K, et al. Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in far-western Region, 2006–2011. BMC Infect Dis. 2013;13(1):604. doi:10.1186/1471-2334-13-60424369908
   PubMedGoogle Scholar
• Deribe K, Hailekiros F, Biadgilign S, Amberbir A, Beyene BK. Defaulters from antiretroviral treatment in Jimma university specialized hospital, Southwest Ethiopia. Trop Med Int Health. 2008;13(3):328–333. doi:10.1111/j.1365-3156.2008.02006.x18298607
   PubMed Web of Science ®Google Scholar
• Geng EH, Nash D, Kambugu A, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7(4):234–244.20820972
   PubMedGoogle Scholar